We are live on
!
Find out more
XT
XTX Topco Portfolio holdings
AUM
$5.75B
1-Year Est. Return
30.56%
This Fund
S&P 500
This Quarter
Est. Return
-18.27%
1 Year Est. Return
+30.56%
3 Year Est. Return
+70.38%
5 Year Est. Return
+43.83%
10 Year Est. Return
–
AUM
$245M
AUM Growth
+$16.7M
(+7.3%)
Cap. Flow
+$61.4M
Cap. Flow
% of AUM
25.11%
Top 10 Holdings %
Top 10 Hldgs %
8.03%
Holding
1,200
New
565
Increased
162
Reduced
81
Closed
389
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
Alphabet (Google) Class A
GOOGL
|
+$4.49M |
| 2 |
Amgen
AMGN
|
+$2.44M |
| 3 |
Carnival Corporation Ltd
CCL
|
+$2.31M |
| 4 |
Caterpillar
CAT
|
+$1.92M |
| 5 |
PepsiCo
PEP
|
+$1.8M |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
UnitedHealth
UNH
|
+$2.15M |
| 2 |
Lam Research
LRCX
|
+$1.81M |
| 3 |
Adobe
ADBE
|
+$1.76M |
| 4 |
Cisco
CSCO
|
+$1.65M |
| 5 |
Johnson & Johnson
JNJ
|
+$1.65M |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Technology | 17.26% |
| 2 | Healthcare | 17.17% |
| 3 | Industrials | 11.48% |
| 4 | Consumer Discretionary | 11.26% |
| 5 | Financials | 11.07% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | |
|---|---|---|---|---|---|---|
|
AERI
526
DELISTED
Aerie Pharmaceuticals
AERI
| $158K | 0.06% |
+21,012
| New | +$148K |
|
527
Takeda Pharmaceutical
TAK
$55.7B
| $157K | 0.06% |
+11,208
| New | +$160K |
|
528
TG Therapeutics
TGTX
$8.53B
| $157K | 0.06% |
+37,019
| New | +$231K |
|
529
Tango Therapeutics
TNGX
$4.35B
| $157K | 0.06% |
+34,569
| New | +$209K |
|
|
NEX
530
DELISTED
NexTier Oilfield Solutions Inc.
NEX
| $157K | 0.06% |
+16,469
| New | +$173K |
|
|
CAN
531
Canaan Creative
CAN
$192M
| $156K | 0.06% |
48,486
-1,252
| -3% | -$4.73K |
|
532
Foghorn Therapeutics
FHTX
$305M
| $156K | 0.06% |
+11,436
| New | +$148K |
|
533
StealthGas
GASS
$329M
| $155K | 0.06% |
+48,401
| New | +$135K |
|
|
ME
534
DELISTED
23andMe Holding Co
ME
| $155K | 0.06% |
3,131
+479
| +18% | +$27.8K |
|
535
Forestar Group
FOR
$1.47B
| $153K | 0.06% |
+11,199
| New | +$176K |
|
536
Ooma
OOMA
$571M
| $153K | 0.06% |
+12,911
| New | +$171K |
|
537
Companhia Siderúrgica Nacional
SID
$1.49B
| $153K | 0.06% |
+52,112
| New | +$220K |
|
538
Millicom
TIGO
$16B
| $153K | 0.06% |
+10,661
| New | +$219K |
|
539
Curis
CRIS
$9.14M
| $151K | 0.06% |
383
+324
| +549% | +$135K |
|
540
Voyager Therapeutics
VYGR
$187M
| $151K | 0.06% |
+25,525
| New | +$172K |
|
541
Aspen Aerogels
ASPN
$385M
| $149K | 0.06% |
+15,106
| New | +$305K |
|
|
BLDP
542
Ballard Power Systems
BLDP
$865M
| $149K | 0.06% |
+23,606
| New | +$189K |
|
543
Smith & Wesson
SWBI
$666M
| $149K | 0.06% |
+11,311
| New | +$164K |
|
|
ICPT
544
DELISTED
Intercept Pharmaceuticals, Inc.
ICPT
| $149K | 0.06% |
+10,784
| New | +$173K |
|
|
RFP
545
DELISTED
Resolute Forest Products Inc.
RFP
| $149K | 0.06% |
+11,660
| New | +$161K |
|
546
Riot Platforms
RIOT
$8.31B
| $148K | 0.06% |
+35,323
| New | +$328K |
|
547
Frontline
FRO
$8.59B
| $147K | 0.06% |
+16,548
| New | +$150K |
|
548
Immersion
IMMR
$256M
| $147K | 0.06% |
+27,591
| New | +$143K |
|
549
Kyndryl
KD
$2.81B
| $147K | 0.06% |
+15,008
| New | +$175K |
|
|
CS
550
DELISTED
Credit Suisse Group
CS
| $145K | 0.06% |
+25,581
| New | +$174K |
|
Similar funds
HW
AAM
RWM
SAM
PP
VH
TSW
KIM
XTX Topco's Q2 2022 Portfolio in Review
As of Q2 2022, XTX Topco held 1,200 positions worth $245M, up 7.3% from $228M the previous quarter. Its ten largest holdings account for 8% of the portfolio.
XTX Topco deployed $61.4M of net new capital in Q2 2022, opening 565 new positions and adding to 162 existing holdings. Its largest new stake was Alphabet (Google) Class A: 38,140 shares worth $4.16M.
By sector, the portfolio is most concentrated in Technology at 17% of assets, down from 20% a quarter earlier, followed by Healthcare and Industrials.
On the sell side, the largest reduction was Johnson & Johnson, an estimated $1.65M trimmed.
- XTX Topco's largest Q2 2022 buy was Alphabet (Google) Class A: 38,140 shares worth $4.16M.
- XTX Topco added most to Dow Inc in Q2 2022, an estimated $1.32M increase.
- XTX Topco's biggest Q2 2022 reduction was Johnson & Johnson, cutting an estimated $1.65M.
- XTX Topco fully exited UnitedHealth in Q2 2022, selling an estimated $2.15M.
- XTX Topco's ten largest holdings make up 8% of its $245M portfolio in Q2 2022.
- XTX Topco opened 565 new positions and closed 389 in Q2 2022.
- XTX Topco's portfolio value rose 7.3% quarter-over-quarter to $245M.
Based on XTX Topco's 13F filing for Q2 2022, filed 15 Aug 2022.